Menopause Hormone Therapy (HRT) in Gilbert, AZ

Bioidentical hormones in Gilbert: what it means

Behind the label "bioidentical hormone replacement therapy" is a plain idea: a hormone whose structure matches the body's own. Estradiol and micronized progesterone are both bioidentical: their structure matches the hormones the ovaries make. Neither has to be compounded: FDA-approved estradiol comes as pills, patches, gels, sprays, vaginal creams and rings, and progesterone as capsules.

Compounded hormones are a different thing: a pharmacy prepares them for one patient, as a cream, a capsule or a pellet. Compounded drugs are not FDA-approved, so the FDA cannot assure their safety, effectiveness or dose. In the FDA's words, it has no evidence that compounded "bioidentical hormones" are safe and effective. When the National Academies reviewed them in 2020, the evidence was mostly low quality, such as anecdotes and patient reports.

Through VevaMD, a physician licensed in Arizona decides whether hormone therapy fits you and, if so, the form: an estradiol pill, patch, cream or vaginal cream, with progesterone if you have a uterus. Pellets are not part of it. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

At 19.5 OB-GYNs per 100,000 residents (53 listed in the NPI registry), Gilbert sits near the national 17.8 and above Arizona's 14.6; 49% of the cities VevaMD covers have a lower rate. Set against the city's 32,902 women aged 45 to 64, that is one OB-GYN for roughly every 620.

Widen the circle and the count grows: 144 in the city or within 10 miles, 520 within 25 miles. For the 2,529,242 people who live within 25 miles, that is 20.6 per 100,000. VevaMD is an online option alongside them: a physician licensed in Arizona reviews your intake from Gilbert without an office visit, and an OB-GYN you already see stays your doctor.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11